Chia Nan University of Pharmacy & Science Institutional Repository:Item 310902800/24211
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 18076/20274 (89%)
造访人次 : 5131370      在线人数 : 1081
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧:
  • 您可在西文检索词汇前后加上"双引号",以获取较精准的检索结果
  • 若欲以作者姓名搜寻,建议至进阶搜寻限定作者字段,可获得较完整数据
  • 进阶搜寻


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/24211


    標題: Development of Dual-acting Modulators for Proteolytic Cleavage of Amyloid Precursor Proteins
    作者: Ming-Kuan Hu (胡明寬)
    日期: 2011
    上傳時間: 2011-06-23 14:57:05 (UTC+8)
    摘要: One of the pathological hallmarks of Alzheimer's disease (AD) is the cerebral accumulation of amyloid plaques, and the major constituents of these plaques are the 40—42 residue amyloid-β peptides (Aβs), to which the amount of generation was dependent on the proteolytic processing of amyloid precursor proteins (APPs) sequentially by the β- and γ-secretases. An alternative processing of APP by α-secretase could be regulated via activation of mitogen-activated protein kinase (MAPK) pathway and considered to be beneficial, because this process generates neuroprotective secretory amyloid precursor protein (sAPP) and thus precludes the production of amyloidogenic Aβs and reduces the risk of AD. On the basis of these investigations, strategies to the development of single chemical entities to modulate multiple targets were suitably applied to the therapeutic approaches for AD. Here, efforts to identify dual-acting molecules and the screeniig for selectivity against γ-secretase and simultaneously modulation of MAPK pathway of these compounds are presented.
    關聯: 2011年台俄有機、藥物與生物化學交流暨藥物化學研討會,起迄日:2011/04/06~2011/04/05,地點:溪頭台大實驗林
    显示于类别:[藥理學院] 2011年台俄有機、藥物與生物化學交流暨藥物化學研討會

    文件中的档案:

    档案 描述 大小格式浏览次数
    il-11.pdf70KbAdobe PDF527检视/开启


    在CNU IR中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈